AddedRisk Factors
We are subject to complex and evolving data privacy, data protection and data security laws, and failure to comply could result in significant costs, liabilities and operational restrictions.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedRisk Factors
Compliance with these evolving requirements may necessitate significant operational changes and could impose substantial and increasing costs over time. Any failure to comply could result in regulatory investigations, significant fines, penalties or restrictions on our ability to process or transfer data across jurisdictions, and reputational harm.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedRisk Factors
issued with voting rights that may adversely affect the voting power of the holders of our common stock by increasing the number of outstanding shares having voting rights and by the creation of class or series voting rights.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RemovedRisk Factors
The costs to manufacture and distribute our products are subject to fluctuation based on a variety of factors. Volatility and increases in commodity raw material (e.g. resins) and packaging component prices, labor, energy and transportation costs, and
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedRisk Factors
We could also be required for a variety of reasons to initiate product recalls, which we have done on several occasions. Any product recalls could have a material adverse effect on our business, financial condition and results of operations.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedRisk Factors
successfully resolve those claims, which would cause us to lose the right to use the intellectual property subject to those claims. If we were to lose the exclusive right to use one or more of our intellectual property rights, the loss of such exclusive right could have a material adverse effect on our financial condition and results of operations.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedRisk Factors
regulatory, legal and tax requirements, collecting and storing customer, consumer, employee, investor and other stakeholder information and personal data and other processes necessary to manage the Company's business.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedRisk Factors
We and certain of our suppliers and customers have been, and likely will continue to be, subject to malware, computer viruses, computer hacking, attempted acts of data theft, phishing, other cyber-attacks and employee error or malfeasance related to information technology systems. We do not believe that any of these attacks or events has had a material adverse impact on our business, but future attacks could result in a serious information security breach and have a material adverse impact on our business, results of operations or financial condition.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RewordedRisk Factors
These systems include programs and processes relating to internal communications and communications with other parties, ordering and managing materials from suppliers, converting materials to finished products, marketing and selling products to customers (including through e-commerce channels), customer order entry and order fulfillment, shipping product to customers, billing customers and receiving and applying payment, processing transactions, summarizing and reporting results of operations, complying with regulatory, legal and tax requirements, collecting and storing customer, consumer, employee, investor and other stakeholder information and personal data and other processes necessary to manage the Company's business.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
Land use, water use, carbon emissions, deforestation, recyclability or recoverability of packaging, plastic waste, ingredients and other sustainability concerns remain key topics with federal, state and local governments, non-governmental organizations, our customers, consumers and investors, which may result in new laws, regulations and requirements that could cause disruptions in or increased costs associated with developing, manufacturing and distributing our products. investors.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
This These trends could be exacerbated by rising costs, including tariffs, trade restrictions, export controls and sanctions, as well as ongoing geopolitical tensions, including conflicts in the Middle East and other regions, and other economic conditions that shift consumer demand to lower-priced products, as well as supply chain issues that result in reduced availability for our products.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
These shortages negatively impacted our results of operations in the fourth quarter of fiscal 2024 2026 and fiscal 2025, and we expect further shortages may have a negative impact on our sales. sales and customer relationships and result in loss of shelf space/digital rank and higher costs.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
During 2025, 2024 and 2023, this This manufacturer accounted for approximately 21%, 20% and 20%, respectively, of our gross revenues in 2026 and 2025 and 20% of our gross sales revenues in 2024, while we accounted for a significant portion of their gross revenues over that time period.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, third parties may assert claims against our intellectual property rights, and we may not be able to successfully resolve those claims, which would cause us to lose the right to use the intellectual property subject to those claims.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, other parties may infringe our intellectual property rights rights, including through e-commerce channels, digital marketplaces or unauthorized online sales, which may be more difficult to monitor and enforce, and may thereby dilute the value of our brands in the marketplace.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we increase the price of our products in order to maintain our current gross margins for our products, the increase may adversely affect demand for, and sales of, our products, especially if consumers shift to lower-priced alternatives or private label products in response to tariff-driven or inflationary price increases, which could have a material adverse effect on our financial condition and results of operations.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
We also operate a three manufacturing facility facilities in Lynchburg, Virginia, the United States, Canada and Australia, which manufactures manufacture products representing approximately 15% 21% of our gross revenues.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
This policy restricts the use of AI technologies by requiring employees to obtain prior approval from the Company’s Vice President of Information Technology, AI Technology Governance Committee, in order to evaluate any potential security, compliance, or operational risks.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
Of those, we had long-term contracts with 16 18 manufacturers that produced items that accounted for approximately 58% 60% of gross sales for 2025, 2026, compared to 26 16 manufacturers with long-term contracts that accounted for approximately 72% 58% of gross sales in 2024. 2025.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedRisk Factors
These privacy and security laws and regulations change frequently, and new legislation continues to be introduced, with over a dozen U.S. states having adopted privacy laws. introduced.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedMD&A
On December 18, 2025, we completed the acquisition of Pillar5, which was funded through a combination of cash on hand and our existing asset-based revolving credit facility.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedMD&A
Based in Arnprior Ontario, Canada, Pillar5 is a leading sterile ophthalmic manufacturer and one of our current Clear Eyes suppliers.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedMD&A
The pro-forma effect of this acquisition on revenues and earnings was not material.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedMD&A
On March 19, 2026, we entered into a definitive agreement to acquire certain assets and assume certain liabilities primarily related to a portfolio of over-the-counter consumer health products, including Breathe Right® and certain other brands from Foundation Consumer Brands, LLC. We anticipate the transaction to close in the first half of fiscal 2027.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
AddedMD&A
During fiscal 2026, we wrote off a supplier loan of $10.3 million, previously included in Accounts receivable, net.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RemovedMD&A
Additionally, our analysis as of February 28, 2025 confirmed that all other indefinite-lived intangible assets had a fair value exceeding their carrying value by at least 10%.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedMD&A
The net proceeds from the new class of Term B-5 Loans were used to refinance our outstanding term loans, finance the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn") pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), and pay fees and expenses incurred in connection with these transactions.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedMD&A
(1)Represents the estimated interest obligations on the outstanding balances at March 31, 2025 of the 2021 Senior Notes, 2019 Senior Notes and 2012 ABL Revolver, assuming scheduled principal payments (based on the terms of the loan agreements). We estimate our future obligations for interest on our variable rate debt, made up of interest on the unused portion of our ABL, by assuming the weighted average interest rate in effect on the variable rate debt obligation at March 31, 2025 remains constant into the future. This is an estimate, as actual rates will vary over time. In addition, we assume that the average balance outstanding for the last month of fiscal 2025 remains the same for the remaining term of the agreement. The actual balance outstanding may fluctuate significantly in future periods, depending on the availability of cash flow from operations and future investing and financing considerations. Estimated interest obligations would be different under different assumptions regarding interest rates or timing of principal payments.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedMD&A
(2)Purchase obligations for inventory costs are legally binding commitments for projected inventory requirements to be utilized during the normal course of our operations.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedMD&A
(3)Purchase obligations for other costs are legally binding commitments for marketing, advertising and capital expenditures. Our capital expenditures primarily relate to manufacturing equipment. Activity costs for molds and equipment to be paid, based solely on a per unit basis without any deadlines for final payment, have been excluded from the table because we are unable to determine the time period over which such activity costs will be paid.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RemovedMD&A
(4)We have excluded obligations related to uncertain tax positions because we cannot reasonably estimate when they will occur.
Read it in 10-K May 9, 2025 at sec.govopen_in_new
RewordedMD&A
As a percentage of total revenues, gross profit increased decreased to 54.7% in 2026 from 55.8% in 2025 from 55.5% in 2024, 2025, primarily due to an increase the decrease in revenue and a decrease in freight costs in related to the acquisition of our North American OTC Healthcare segment. Canadian manufacturing facility.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
Our analysis at as of February 28, 2025 determined 2026 confirmed that all reporting units indefinite-lived intangible assets had a fair value that exceeded exceeding their carrying value by at least 10%. 10%, with the exception of Monistat within our North American Women's Health reporting unit.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
We performed a sensitivity analysis on of our weighted average cost of capital, and we determined that a 50-basis point increase in the weighted average cost of capital used to value all of our indefinite-lived intangible assets would not have resulted in any an impairment charge of our reporting units' fair value being less than their carrying value. $16.6 million.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The contribution margin increase decrease as a percentage of revenues revenue was primarily due to the increase decrease in gross profit margin noted above and decreased above, partly offset by a decrease in advertising and marketing spend in North America during 2025. spend.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
A description The details of recently issued and adopted accounting pronouncements is this acquisition are included in the notes to the Consolidated Financial Statements in Part II, Item 8, Note 1 2 of this Annual Report. Report on Form 10-K.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
As a percentage of International OTC Healthcare revenues, gross profit increased decreased to 54.1% during 2026 from 58.1% during 2025 from 57.2% during 2024, 2025, primarily due to an increase in revenue increased inflation as well as channel and product mix.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The $10.7 $2.6 million increase decrease was mainly attributable to an increase a decrease in sales in the Gastrointestinal and Dermatologicals categories, Eye & Ear Care category, partly offset by a decrease an increase in sales in the Women's Health and Cough & Cold categories.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in general and administrative expenses was primarily due to increases in compensation compensation-related expenses, acquisition-related costs and professional fees. an increase in our allowance for doubtful accounts pertaining to one specific customer.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The contribution margin decrease as a percentage of revenues was primarily due to an increase the decrease in advertising and marketing spend internationally in 2025. gross profit margin noted above.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in the effective tax rate in 2025 2026 compared to 2024 2025 was primarily due to the mix of earnings in the U.S. and foreign jurisdictions. jurisdictions and establishing a taxable presence in a new state.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The $19.2 $6.1 million increase in net cash provided by operating activities was due to decreased the timing of working capital and an increase capital, partially offset by a decrease in net income before non-cash items.
Read it in 10-K May 14, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease of $58.9 $26.0 million in net cash used in financing activities was primarily due to a decrease in net debt repayments of $90.0 $138.0 million, partly offset by an increase in the repurchase of shares of our common stock in conjunction with our share repurchase program of $26.5 $104.8 million and a decrease in proceeds from the exercise of stock options of $3.3 $10.5 million.
Read it in 10-K May 14, 2026 at sec.govopen_in_new